ReP USP - Resultado da busca

Artigo de periodico
Experiences of women with advanced cervical cancer before starting the treatment: systematic review of qualitative studies (2023)
Reis, Bruna Sena; Nogueira, Cristiane de Matos; Meneses, Aerica de Figueiredo Pereira ; Mellado, Bruna Helena; Reis, Francisco José Candido dos
Source: International Journal of Gynecology & Obstetrics. Unidade: FMRP
Subjects: NEOPLASIAS DO COLO UTERINO, DIAGNÓSTICO, ASSISTÊNCIA À SAÚDE, CONHECIMENTOS, ATITUDES E PRÁTICA, ADAPTAÇÃO PSICOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REIS, Bruna Sena et al. Experiences of women with advanced cervical cancer before starting the treatment: systematic review of qualitative studies. International Journal of Gynecology & Obstetrics, v. 161, n. 1, p. 8-16, 2023Tradução . . Disponível em: https://doi.org/10.1002/ijgo.14491. Acesso em: 06 jul. 2024.
APA
Reis, B. S., Nogueira, C. de M., Meneses, A. de F. P., Mellado, B. H., & Reis, F. J. C. dos. (2023). Experiences of women with advanced cervical cancer before starting the treatment: systematic review of qualitative studies. International Journal of Gynecology & Obstetrics, 161( 1), 8-16. doi:10.1002/ijgo.14491
NLM
Reis BS, Nogueira C de M, Meneses A de FP, Mellado BH, Reis FJC dos. Experiences of women with advanced cervical cancer before starting the treatment: systematic review of qualitative studies [Internet]. International Journal of Gynecology & Obstetrics. 2023 ; 161( 1): 8-16.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1002/ijgo.14491
Vancouver
Reis BS, Nogueira C de M, Meneses A de FP, Mellado BH, Reis FJC dos. Experiences of women with advanced cervical cancer before starting the treatment: systematic review of qualitative studies [Internet]. International Journal of Gynecology & Obstetrics. 2023 ; 161( 1): 8-16.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1002/ijgo.14491
Artigo de periodico
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study (2023)
Weir, Ashley; Kang, Eun-Young; Meagher, Nicola S.; Nelson, Gregg S.; Ghatage, Prafull; Lee, Cheng-Han; Riggan, Marjorie J.; Ryan, Andy; Singh, Naveena; Alsop, Jennifer; Anglesio, Michael S.; Bisinoto, Christiani; Ramus, Susan J. ; Reis, Francisco José Candido dos
Source: British Journal of Cancer. Unidade: FMRP
Subjects: BIOMARCADORES, ADENOCARCINOMA, NEOPLASIAS OVARIANAS, PROGNÓSTICO, RNA MENSAGEIRO, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEIR, Ashley et al. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study. British Journal of Cancer, v. 128, n. 1, p. 137-147, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41416-022-02014-y. Acesso em: 06 jul. 2024.
APA
Weir, A., Kang, E. -Y., Meagher, N. S., Nelson, G. S., Ghatage, P., Lee, C. -H., et al. (2023). Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study. British Journal of Cancer, 128( 1), 137-147. doi:10.1038/s41416-022-02014-y
NLM
Weir A, Kang E-Y, Meagher NS, Nelson GS, Ghatage P, Lee C-H, Riggan MJ, Ryan A, Singh N, Alsop J, Anglesio MS, Bisinoto C, Ramus SJ, Reis FJC dos. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study [Internet]. British Journal of Cancer. 2023 ; 128( 1): 137-147.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1038/s41416-022-02014-y
Vancouver
Weir A, Kang E-Y, Meagher NS, Nelson GS, Ghatage P, Lee C-H, Riggan MJ, Ryan A, Singh N, Alsop J, Anglesio MS, Bisinoto C, Ramus SJ, Reis FJC dos. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study [Internet]. British Journal of Cancer. 2023 ; 128( 1): 137-147.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1038/s41416-022-02014-y
Artigo de periodico
Profiling the immune landscape in mucinous ovarian carcinoma (2023)
Meagher, Nicola S.; Hamilton, Phineas; Milne, Katy; Thornton, Shelby; Harris, Bronwyn; Weir, Ashley; Alsop, Jennifer; Bisinoto, Christiani; Brenton, James D.; Brooks-Wilson, Angela; Chiu, Derek S.; Reis, Francisco José Candido dos ; Ramus, Susan J; Cook, Linda S.
Source: Gynecologic Oncology. Unidade: FMRP
Subjects: CARCINOMA, NEOPLASIAS OVARIANAS, FATORES DE TRANSCRIÇÃO, ANTÍGENOS, LINFÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEAGHER, Nicola S. et al. Profiling the immune landscape in mucinous ovarian carcinoma. Gynecologic Oncology, v. 168, p. 23-31, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ygyno.2022.10.022. Acesso em: 06 jul. 2024.
APA
Meagher, N. S., Hamilton, P., Milne, K., Thornton, S., Harris, B., Weir, A., et al. (2023). Profiling the immune landscape in mucinous ovarian carcinoma. Gynecologic Oncology, 168, 23-31. doi:10.1016/j.ygyno.2022.10.022
NLM
Meagher NS, Hamilton P, Milne K, Thornton S, Harris B, Weir A, Alsop J, Bisinoto C, Brenton JD, Brooks-Wilson A, Chiu DS, Reis FJC dos, Ramus SJ, Cook LS. Profiling the immune landscape in mucinous ovarian carcinoma [Internet]. Gynecologic Oncology. 2023 ; 168 23-31.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1016/j.ygyno.2022.10.022
Vancouver
Meagher NS, Hamilton P, Milne K, Thornton S, Harris B, Weir A, Alsop J, Bisinoto C, Brenton JD, Brooks-Wilson A, Chiu DS, Reis FJC dos, Ramus SJ, Cook LS. Profiling the immune landscape in mucinous ovarian carcinoma [Internet]. Gynecologic Oncology. 2023 ; 168 23-31.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1016/j.ygyno.2022.10.022
Artigo de periodico
Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador (2022)
Rosero, Carmen Yolanda de Las Mercedes Villa; Mazin, Suleimy Cristina; Nogueira, Antonio Alberto; Costales, José Antonio Vargas; Rosa e Silva, Júlio César ; Reis, Francisco José Candido dos ; Poli Netto, Omero Benedicto
Source: BMC Women's Health. Unidade: FMRP
Subjects: PELVE, PREVALÊNCIA, ESTUDOS TRANSVERSAIS, QUALIDADE DE VIDA, DOR CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSERO, Carmen Yolanda de Las Mercedes Villa et al. Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador. BMC Women's Health, v. 22, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12905-022-01948-y. Acesso em: 06 jul. 2024.
APA
Rosero, C. Y. de L. M. V., Mazin, S. C., Nogueira, A. A., Costales, J. A. V., Rosa e Silva, J. C., Reis, F. J. C. dos, & Poli Netto, O. B. (2022). Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador. BMC Women's Health, 22, 1-15. doi:10.1186/s12905-022-01948-y
NLM
Rosero CY de LMV, Mazin SC, Nogueira AA, Costales JAV, Rosa e Silva JC, Reis FJC dos, Poli Netto OB. Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador [Internet]. BMC Women's Health. 2022 ; 22 1-15.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1186/s12905-022-01948-y
Vancouver
Rosero CY de LMV, Mazin SC, Nogueira AA, Costales JAV, Rosa e Silva JC, Reis FJC dos, Poli Netto OB. Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador [Internet]. BMC Women's Health. 2022 ; 22 1-15.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1186/s12905-022-01948-y
Artigo de periodico
A new method for obtaining tumor interstitial fluid applied to cytokine analysis of breast carcinoma samples (2022)
Dantas, Felipe Torres; Silva, Pedro Henrique Felix ; Carrara, Helio Humberto Angotti ; Reis, Francisco José Candido dos ; Taba Júnior, Mário ; Souza, Sérgio Luis Scombatti de ; Palioto, Daniela Bazan
Source: Anticancer Research. Unidades: FMRP, FORP
Subjects: BIOMARCADORES, BIÓPSIA COM AGULHA DE GRANDE CALIBRE, NEOPLASIAS MAMÁRIAS, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANTAS, Felipe Torres et al. A new method for obtaining tumor interstitial fluid applied to cytokine analysis of breast carcinoma samples. Anticancer Research, v. 42, n. 3, p. 1327-1332, 2022Tradução . . Disponível em: https://doi.org/10.21873/anticanres.15600. Acesso em: 06 jul. 2024.
APA
Dantas, F. T., Silva, P. H. F., Carrara, H. H. A., Reis, F. J. C. dos, Taba Júnior, M., Souza, S. L. S. de, & Palioto, D. B. (2022). A new method for obtaining tumor interstitial fluid applied to cytokine analysis of breast carcinoma samples. Anticancer Research, 42( 3), 1327-1332. doi:10.21873/anticanres.15600
NLM
Dantas FT, Silva PHF, Carrara HHA, Reis FJC dos, Taba Júnior M, Souza SLS de, Palioto DB. A new method for obtaining tumor interstitial fluid applied to cytokine analysis of breast carcinoma samples [Internet]. Anticancer Research. 2022 ; 42( 3): 1327-1332.[citado 2024 jul. 06 ] Available from: https://doi.org/10.21873/anticanres.15600
Vancouver
Dantas FT, Silva PHF, Carrara HHA, Reis FJC dos, Taba Júnior M, Souza SLS de, Palioto DB. A new method for obtaining tumor interstitial fluid applied to cytokine analysis of breast carcinoma samples [Internet]. Anticancer Research. 2022 ; 42( 3): 1327-1332.[citado 2024 jul. 06 ] Available from: https://doi.org/10.21873/anticanres.15600
Artigo de periodico
Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil (2022)
Magario, Marcos Benini; Santos, Raquel Rocha dos ; Teixeira, Lorena Alves ; Tiezzi, Daniel Guimarães ; Pimentel, Franklin Fernandes ; Carrara, Helio Humberto Angotti ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, PROGNÓSTICO, SOBREVIDA, VALIDAÇÃO DE MODELOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGARIO, Marcos Benini et al. Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil. Brazilian Journal of Medical and Biological Research, v. 55, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1590/1414-431X2022e12109. Acesso em: 06 jul. 2024.
APA
Magario, M. B., Santos, R. R. dos, Teixeira, L. A., Tiezzi, D. G., Pimentel, F. F., Carrara, H. H. A., et al. (2022). Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil. Brazilian Journal of Medical and Biological Research, 55, 1-8. doi:10.1590/1414-431X2022e12109
NLM
Magario MB, Santos RR dos, Teixeira LA, Tiezzi DG, Pimentel FF, Carrara HHA, Andrade JM de, Reis FJC dos. Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-8.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1590/1414-431X2022e12109
Vancouver
Magario MB, Santos RR dos, Teixeira LA, Tiezzi DG, Pimentel FF, Carrara HHA, Andrade JM de, Reis FJC dos. Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-8.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1590/1414-431X2022e12109
Artigo de periodico
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma (2022)
Kang, Eun-Young; Millstein, Joshua; Popovic, Gordana; Meagher, Nicola S.; Bolithon, Adelyn; Talhouk, Aline; Chiu, Derek S.; Anglesio, Michael S.; Leung, Betty; Tang, Katrina; Lambie, Neil; Pavanello, Marina; Ramus, Susan J.; Köbel, Martin; Reis, Francisco José Candido dos
Source: Virchows Archiv. Unidade: FMRP
Subjects: BIOMARCADORES, PROLIFERAÇÃO CELULAR, NEOPLASIAS OVARIANAS, RNA MENSAGEIRO, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KANG, Eun-Young et al. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. Virchows Archiv, v. 480, n. 4, p. 855-871, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00428-021-03232-0. Acesso em: 06 jul. 2024.
APA
Kang, E. -Y., Millstein, J., Popovic, G., Meagher, N. S., Bolithon, A., Talhouk, A., et al. (2022). MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. Virchows Archiv, 480( 4), 855-871. doi:10.1007/s00428-021-03232-0
NLM
Kang E-Y, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, Anglesio MS, Leung B, Tang K, Lambie N, Pavanello M, Ramus SJ, Köbel M, Reis FJC dos. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma [Internet]. Virchows Archiv. 2022 ; 480( 4): 855-871.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1007/s00428-021-03232-0
Vancouver
Kang E-Y, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, Anglesio MS, Leung B, Tang K, Lambie N, Pavanello M, Ramus SJ, Köbel M, Reis FJC dos. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma [Internet]. Virchows Archiv. 2022 ; 480( 4): 855-871.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1007/s00428-021-03232-0
Artigo de periodico
Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors (2021)
Lanfredi, Guilherme Pauperio ; Thome, Carolina H.; Ferreira, Germano Aguiar ; Silvestrini, Virgínia Campos; Masson, Ana Paula; Vargas, Alessandra Pinto ; Grassi, Mariana L.; Poersch, Aline; Reis, Francisco José Candido dos; Faça, Vitor Marcel
Source: Biochimica et Biophysica Acta: Proteins and Proteomics. Unidade: FMRP
Subjects: BIOMARCADORES, NEOPLASIAS, INTERAÇÃO CELULAR, CROMATOGRAFIA LÍQUIDA, EXPRESSÃO GÊNICA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LANFREDI, Guilherme Pauperio et al. Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors. Biochimica et Biophysica Acta: Proteins and Proteomics, v. 1869, n. 6, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bbapap.2021.140623. Acesso em: 06 jul. 2024.
APA
Lanfredi, G. P., Thome, C. H., Ferreira, G. A., Silvestrini, V. C., Masson, A. P., Vargas, A. P., et al. (2021). Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors. Biochimica et Biophysica Acta: Proteins and Proteomics, 1869( 6). doi:10.1016/j.bbapap.2021.140623
NLM
Lanfredi GP, Thome CH, Ferreira GA, Silvestrini VC, Masson AP, Vargas AP, Grassi ML, Poersch A, Reis FJC dos, Faça VM. Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors [Internet]. Biochimica et Biophysica Acta: Proteins and Proteomics. 2021 ; 1869( 6):[citado 2024 jul. 06 ] Available from: https://doi.org/10.1016/j.bbapap.2021.140623
Vancouver
Lanfredi GP, Thome CH, Ferreira GA, Silvestrini VC, Masson AP, Vargas AP, Grassi ML, Poersch A, Reis FJC dos, Faça VM. Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors [Internet]. Biochimica et Biophysica Acta: Proteins and Proteomics. 2021 ; 1869( 6):[citado 2024 jul. 06 ] Available from: https://doi.org/10.1016/j.bbapap.2021.140623
Artigo de periodico
Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients (2021)
Orlandini, Leonardo Fleury ; Pimentel, F. F.; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos; Mattos-Arruda, L. de; Tiezzi, Daniel Guimarães
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, OBESIDADE, PROGNÓSTICO, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORLANDINI, Leonardo Fleury et al. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients. Brazilian Journal of Medical and Biological Research, v. 54, n. 10, 2021Tradução . . Disponível em: https://doi.org/10.1590/1414-431X2021e11409. Acesso em: 06 jul. 2024.
APA
Orlandini, L. F., Pimentel, F. F., Andrade, J. M. de, Reis, F. J. C. dos, Mattos-Arruda, L. de, & Tiezzi, D. G. (2021). Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients. Brazilian Journal of Medical and Biological Research, 54( 10). doi:10.1590/1414-431X2021e11409
NLM
Orlandini LF, Pimentel FF, Andrade JM de, Reis FJC dos, Mattos-Arruda L de, Tiezzi DG. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2021 ; 54( 10):[citado 2024 jul. 06 ] Available from: https://doi.org/10.1590/1414-431X2021e11409
Vancouver
Orlandini LF, Pimentel FF, Andrade JM de, Reis FJC dos, Mattos-Arruda L de, Tiezzi DG. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2021 ; 54( 10):[citado 2024 jul. 06 ] Available from: https://doi.org/10.1590/1414-431X2021e11409
Artigo de periodico
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium (2020)
Martins, Filipe Correia; Couturier, Dominique-Laurent; Paterson, Anna; Karnezis, Anthony N.; Chow, Christine; Nazeran, Tayyebeh M.; Odunsi, Adekunle; Sousa, Christiani B. de; Tiezzi, Daniel Guimarães ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Source: British Journal of Cancer. Unidade: FMRP
Subjects: ADENOCARCINOMA, MORTALIDADE, BIOMARCADORES, NEOPLASIAS OVARIANAS, GENÉTICA, ESTUDOS DE COORTES, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Filipe Correia et al. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. British Journal of Cancer, v. 123, p. 793-802, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41416-020-0900-0. Acesso em: 06 jul. 2024.
APA
Martins, F. C., Couturier, D. -L., Paterson, A., Karnezis, A. N., Chow, C., Nazeran, T. M., et al. (2020). Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. British Journal of Cancer, 123, 793-802. doi:10.1038/s41416-020-0900-0
NLM
Martins FC, Couturier D-L, Paterson A, Karnezis AN, Chow C, Nazeran TM, Odunsi A, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium [Internet]. British Journal of Cancer. 2020 ; 123 793-802.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1038/s41416-020-0900-0
Vancouver
Martins FC, Couturier D-L, Paterson A, Karnezis AN, Chow C, Nazeran TM, Odunsi A, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium [Internet]. British Journal of Cancer. 2020 ; 123 793-802.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1038/s41416-020-0900-0
Artigo de periodico
The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers (2019)
Carvalho, Vinícius Pereira de; Grassi, Mariana Lopes; Palma, Camila de Souza ; Carrara, Helio Humberto Angotti ; Faça, Vitor Marcel ; Reis, Francisco José Candido dos ; Poersch, Aline
Source: Translational Research. Unidades: FMRP, FEA
Subjects: BIOMARCADORES, NEOPLASIAS OVARIANAS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Vinícius Pereira de et al. The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers. Translational Research, v. 206, p. 71-90, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.trsl.2018.11.001. Acesso em: 06 jul. 2024.
APA
Carvalho, V. P. de, Grassi, M. L., Palma, C. de S., Carrara, H. H. A., Faça, V. M., Reis, F. J. C. dos, & Poersch, A. (2019). The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers. Translational Research, 206, 71-90. doi:10.1016/j.trsl.2018.11.001
NLM
Carvalho VP de, Grassi ML, Palma C de S, Carrara HHA, Faça VM, Reis FJC dos, Poersch A. The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers [Internet]. Translational Research. 2019 ; 206 71-90.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1016/j.trsl.2018.11.001
Vancouver
Carvalho VP de, Grassi ML, Palma C de S, Carrara HHA, Faça VM, Reis FJC dos, Poersch A. The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers [Internet]. Translational Research. 2019 ; 206 71-90.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1016/j.trsl.2018.11.001

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration